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OBJECTIVES The goal of this study was to determine the value of thallium201 single photon emission
computed tomography (SPECT) imaging for prediction of all-cause mortality when
considered along with functional capacity and heart rate recovery.
BACKGROUND Myocardial perfusion defects identified by thallium201 SPECT imaging are predictive of
cardiac events. Functional capacity and heart rate recovery are exercise measures that also have
prognostic implications.
METHODS We followed 7,163 consecutive adults referred for symptom-limited exercise thallium
SPECT (mean age 60 6 10, 25% women) for 6.7 years. Using information theory, we
identified a probable best model relating nuclear findings to outcome to calculate a prognostic
nuclear score.
RESULTS There were 855 deaths. Intermediate- and high-risk prognostic nuclear scores were noted in
28% and 10% of patients. Compared with those with low-risk scans, patients with an
intermediate-risk score were at increased risk for death (14% vs. 9%, hazard ratio: 1.67, 95%
confidence interval [CI]: 1.44 to 1.95, p , 0.0001), while those with high-risk scores were
at greater risk (24%, hazard ratio: 2.98, 95% CI: 2.49 to 3.56, p , 0.0001). In multivariable
analyses that adjusted for clinical characteristics, functional capacity and heart rate recovery,
an intermediate-risk nuclear score remained predictive of death (adjusted hazard ratio: 1.50,
95% CI: 1.28 to 1.76, p , 0.0001), as did a high-risk score (adjusted hazard ratio: 2.76, 95%
CI: 2.13 to 2.56, p , 0.0001). Impaired functional capacity and decreased heart rate recovery
provided additional prognostic information.
CONCLUSIONS Myocardial perfusion defects detected by thallium SPECT imaging are independently
predictive of long-term all-cause death, even after accounting for exercise capacity, heart rate
recovery and other potential confounders. (J Am Coll Cardiol 2001;37:1558–64) © 2001 by
the American College of Cardiology
Myocardial perfusion imaging is used for diagnosing coro-
nary artery disease and for risk stratification in patients with
known or suspected disease (1–5). Although imaging results
are often considered alongside results of exercise electrocar-
diography for prediction of cardiac events, recent studies
have highlighted the ability of nonelectrocardiographic
exercise measures, such as functional capacity (6,7) and
heart rate recovery (8,9), to predict mortality. Relatively
little is known about how to best integrate these exercise
measures with nuclear perfusion abnormalities for optimal
risk stratification. In this study, we sought to assess the
independent long-term importance of thallium201 single
photon emission computed tomography (SPECT) perfu-
sion abnormalities relative to functional capacity and heart
rate recovery for prediction of all-cause mortality in a large
cohort of patients. All-cause mortality was studied as an
objective and unbiased end point (10,11).
METHODS
Patient sample. Consecutive adults (age $30 years) re-
ferred for thallium SPECT imaging in conjunction with
symptom-limited exercise testing between September 1990
and December 1993 at the Cleveland Clinic Foundation
were studied. Patients with known heart failure or left
ventricular dysfunction (ejection fraction #40%), valvular
disease and a history of pacemaker implantation were
excluded. Because we used the Social Security Death Index
(12) for assessing outcome, foreign nationals were also
excluded. The study protocol was approved by the local
institutional review board.
Clinical data. The methods used for prospective study of
patients undergoing stress testing at our institution have
been described in detail elsewhere (6,13). Since 1990, all
patients undergoing stress testing undergo a structured
interview and chart review. Data collected prospectively
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include existing medical diagnoses, symptoms, risk factors,
medications and prior procedures. All data are entered
on-line before exercise testing; thus, clinical data collected
are not influenced by stress or nuclear study results.
Exercise testing, functional capacity and heart rate re-
covery. The methods of exercise testing and prospective,
computerized data collection used in our laboratory have
been described in detail elsewhere (13,14). Estimated func-
tional capacity in metabolic equivalents (METS) was clas-
sified as high, good, average, fair or poor for age and gender
based on a classification system (6) that has been validated.
Patients were unfit if their age- and gender-based functional
capacity was fair or poor. Heart rate recovery was defined as
the difference between heart rate at peak exercise and 1 min
into a recovery cool-down period; a value of #12 beats/min
was abnormal (8). We chose not to study chronotropic
response to exercise (13,15) because patients taking beta-
adrenergic blocking agents were not excluded. We did not
analyze ST-segment responses or Duke treadmill scores
(16,17) because of the presence of factors such as digoxin
use or marked baseline electrocardiographic abnormalities
that would limit their interpretation.
Thallium201 SPECT imaging. We have published scinti-
graphic methods used in our laboratory in the early 1990s
(18,19). The heart was divided into twelve segments and, to
avoid any inherent prognostic limitation related to a 12-
segment model (20), each segment was weighted according
to its relative contribution to total left ventricular mass:
anterior (weighted by 3 mU), anterior-lateral (3 mU),
anterior-septal (3 mU), septal (2 mU), apical (1 mU),
inferior (2 mU), inferior-lateral (2 mU), inferior-septal
(2 mU), lateral (3 mU), posterior (1 mU), posterior-lateral
(1 mU) and posterior-septal (1 mU). Each segment was
coded as normal, fixed (scar) or reversible (ischemia). The
justification for mass weightings has been reported (20). In
cases of suspected artifact or attenuation, the segment was
considered normal.
As previously described (18), images were displayed and
interpreted using quantitative color scales. Myocardial
counts were referenced to peak myocardial activity on the
resting images; thus, counts were expressed as a percent of
maximal myocardial activity on the redistribution images.
Segments were considered normal if the count variation
within the segment was #20% compared with the segment
with the highest count rate. For the apex and diaphragmatic
segments, a range of 30% to 40% was allowed. Ischemia was
considered present if the counting rate increased by $20%
on redistribution images; if the segment activity increased
by ,20%, scar was considered present. Segments were only
considered abnormal if the suspected defect was seen on two
or more consecutive slices and could be verified in an
orthogonal plane. Although only one reader evaluated each
study, that reader was blinded to clinical history, results of
prior coronary arteriograms, results of the exercise test
(except for peak heart rate) and the hypothesis of this study.
End points. The primary end point was all-cause mortality
as assessed by the Social Security Death Index (12). We
have described the high specificity and sensitivity of this
measure in detail elsewhere (21). The mean follow-up was
6.7 years, with a minimum follow-up among survivors of 4.5
years.
Statistical analyses. Clinical, exercise and scintigraphic
abnormalities were related to time-to-death using the Cox
proportional hazards model (22). The proportional hazards
assumption was verified by inspection of log (-log [survival
function]) curves. Unadjusted survival estimates were calcu-
lated using the Kaplan-Meier product-limit technique (23),
while adjusted survival functions and confidence limits were
calculated and plotted based on a likelihood-based approach
estimation of the baseline survivorship function (24).
A number of potential nuclear abnormalities have been
considered as prognostically important, including the quan-
tity and distribution of scar and ischemic defects (1). To
determine how best to characterize perfusion defects for
prediction of risk, we used information theory (25), first
identifying an optimal model and then determining the
most likely parameter estimates (coefficients). Seven poten-
tial models were chosen prospectively: 1) the presence of any
defect; 2) the presence of any reversible defect; 3) the
presence of defects in more than one vascular territory; 4)
the total mass of left ventricular myocardium with perfusion
defects of any type (on a scale of 0 to 24), in effect, a
modified summed stress score (1); 5) the total mass of scar;
6) the total mass of ischemia; and 7) a composite of scar and
ischemia mass, with each type of abnormality considered
and weighted differently.
To determine which model was best, Akaike Information
Criterion (25,26) values and weights were calculated for
each model. As shown in Table 1, the best model was the
composite of the masses of scar and ischemia, with a 92%
probability of best fit. This was verified by performing a
series of 100 bootstrap resamplings and Cox modeling for
variable selection; the composite model was chosen as best
94% of the time. The bootstrap resamplings approach has
been shown to be more efficient for model validation than
the simple identification of separate “test” and “validation”
datasets (27,28).
To determine parameter coefficients, 500 bootstrap re-
samplings were performed, and a composite prognostic
nuclear score was derived from the resulting median values
of each beta coefficient from the Cox regression model. The
score was calculated as: score 5 scar mass 1 0.5 (ischemia
mass). We prospectively divided subjects into patients with
normal scans (score 5 0), patients with intermediate risk
Abbreviations and Acronyms
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scans (abnormal scans but with scores below the 90th
percentile, i.e., score .0 and ,8) and patients with high-
risk scans (scores above the 90th percentile, i.e., score $8).
The associations of intermediate- and high-risk compos-
ite prognostic nuclear scores with mortality were assessed in
several prespecified subgroups, and potential interactions
were explored. Particular attention was paid a priori to
subgroups with impaired physical fitness, abnormal heart
rate recovery or both, along with whether or not prior
revascularization had been performed.
Multivariable models were used to assess the independent
association of intermediate- and high-risk nuclear scores.
The results were validated by two series of bootstrapping
resamplings (27,29,30), with consideration of variable se-
lection first and determination of parameter coefficients for
variables that entered at least 50% of models second. A p
value of ,0.05 was required for variable retention. No
variables were forced. We only considered variables available
to clinicians at the time of the stress test. All analyses were
performed using the SAS 6.12 system (SAS, Inc., Cary,
North Carolina).
RESULTS
Baseline and exercise characteristics. The number of
patients who were eligible was 7,163 (age 60 6 10, 25%
women). Thallium SPECT abnormalities were present in
2,817 patients (39%); reversible defects were noted in 1,201
(17%). Based on their composite nuclear prognostic score,
patients were classified as low-risk, intermediate-risk and
high-risk in 62%, 28% and 10% of cases. Fair or poor
physical fitness was found in 2,674 patients (37%); an
abnormal heart rate recovery of #12 beats/min was present
in 2,612 patients (37%).
Baseline clinical and exercise characteristics according to
the composite prognostic nuclear score are summarized in
Table 2. Compared with patients with low-risk or
intermediate-risk composite prognostic nuclear scores, pa-
tients with high-risk scores were older, more likely to be
men and more likely to have diabetes, Q-waves, a history of
prior coronary bypass surgery, more likely to be taking
digoxin or beta-blockers and were more likely to have
impaired physical fitness or an abnormal heart rate recovery.
Thallium SPECT perfusion defects and mortality. Dur-
ing 47,717 person-years of follow-up, there were 855
deaths. Compared with patients with normal nuclear scans
who had a seven-year death rate of 9%, patients with
intermediate- and high-risk nuclear scores had increased
death rates of 14% and 24% (hazard ratios for intermediate-
and high-risk scans 1.67, 95% confidence interval [CI]: 1.44
to 1.95 and 2.98, 95% CI: 2.49 to 3.56). Hazard ratios
according to nuclear score in a number of prespecified
Table 1. Thallium SPECT Models for Prediction of All-cause Mortality With Akaike
Information Criterion Scores and Weights
Model (Variables) Hazard Ratio (95% CI) Di* vi†
Any defect 1.99 (1.74 to 2.28) 32.0 , 0.01
Any ischemia 1.46 (1.24 to 1.72) 113.5 , 0.01
Defects involving more than one vascular
territory
1.64 (1.35 to 1.98) 110.5 , 0.01
Total sum score:
1) Each additional abnormal mass unit
(of a possible 24)
1.08 (1.07 to 1.09) 5.0 0.08
Total scar mass:
1) Each additional mass unit of scar
(of a possible 24)
1.09 (1.08 to 1.11) 12.3 , 0.01
Total ischemic segments:
1) Each additional mass unit of
ischemia (of a possible 24)
1.05 (1.02 to 1.08) 120.1 , 0.01
Composite scar and ischemia:
1) Each additional mass unit of scar 1.09 (1.08 to 1.11) 0.0 0.92
2) Each additional mass unit of
ischemia
1.05 (1.03 to 1.08)
*Difference between Akaike information criterion (AIC) of given model i and AIC of the best model, that is, the model with
the lowest AIC value. The AIC is calculated as: AIC 5 22*log likelihood 1 2 (p 1 2), where p is the number of parameters
in the model. A value of 0 implies the best model. A low value for Di implies a better fit.
†Akaike weight, which is an estimate of the likelihood that a given model i is in fact the best model of the ones studied. Thus,
the value of 0.92 for the composite model in the last row suggests that there is a 92% probability that this is the best model. A
very low value (e.g., ,0.01) suggests that it is very unlikely that the given model i is the best model.
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subgroups were similar. An interaction was noted whereby
high-risk scans were less predictive in patients taking
beta-blockers (hazard ratios: 1.87 vs. 3.45, p for interaction:
0.004).
Figure 1 shows seven-year mortality according to the
number of exercise abnormalities and nuclear scores among
patients who had not undergone prior revascularization.
Patients who were physically fit and who had normal heart
rate recovery were at low risk (,1% per year), irrespective of
nuclear score. Conversely, patients who were both physically
unfit and who had an abnormal heart rate recovery were at
very high risk for death (.3% per year), even with normal
nuclear findings. Patients who had either impaired physical
fitness or an abnormal heart rate recovery, but not both, had
intermediate to high risks for death, depending on the
nuclear score. Figures 2 and 3 show analogous seven-year
mortality among patients who had undergone prior coro-
nary artery bypass grafting or prior percutaneous interven-
tion (but without prior bypass grafting). Within each of the
three exercise groups, abnormal nuclear scans were associ-
ated with increased risk.
Multivariable analyses. After adjusting for age; gender;
resting blood pressure and heart rate; hypertension; diabe-
tes; smoking; chronic lung disease; ECG findings including
Q waves, left ventricular hypertrophy, left and right bundle
branch block and atrial fibrillation; prior coronary bypass
grafting; prior percutaneous revascularization; use of medi-
cations including aspirin, lipid-lowering drugs, beta-
blockers, nondihydropyridine and dihydropyridines calcium
channel blockers, angiotensin-converting enzyme inhibi-
tors, vasodilators, diuretics and digoxin; functional capacity;
heart rate recovery and interaction terms, an intermediate
risk nuclear score remained associated with increased risk of









Age (yrs) 59 6 11 61 6 10 62 6 10
Women 1,524 (34%) 211 (11%) 74 (10%)
Resting systolic BP (mm Hg) 137 6 19 139 6 20 137 6 19
Resting heart rate (beats/min) 76 6 13 74 6 13 75 6 12
Hypertension 1,968 (44%) 968 (49%) 353 (47%)
Diabetes 511 (12%) 293 (15%) 134 (18%)
Current smoking 525 (12%) 227 (11%) 78 (11%)
Chronic lung disease 111 (3%) 52 (3%) 18 (2%)
Q-wave on ECG 285 (6%) 472 (24%) 429 (58%)
Left ventricular hypertrophy* 125 (3%) 113 (6%) 55 (7%)
Left bundle branch block 57 (1%) 58 (3%) 37 (5%)
Right bundle branch block 98 (2%) 62 (3%) 31 (4%)
Atrial fibrillation 65 (1%) 31 (2%) 15 (2%)
Prior coronary bypass 755 (17%) 659 (33%) 322 (44%)
Prior percutaneous procedure 602 (14%) 424 (21%) 170 (23%)
Beta-blocker 700 (16%) 483 (24%) 218 (29%)
Calcium blocker 1,488 (34%) 966 (49%) 336 (45%)
Dihydropyridine 476 (11%) 311 (16%) 119 (16%)
ACE inhibitor 347 (8%) 151 (8%) 67 (9%)
Diuretic 723 (16%) 275 (14%) 145 (20%)
Digoxin 271 (6%) 156 (8%) 131 (18%)
Exercise capacity (METS) 8.4 6 2.4 8.2 6 2.4 7.6 6 2.3
Impaired fitness 1,516 (34%) 781 (39%) 377 (51%)
Heart rate recovery (beats/min) 18 6 8 17 6 8 17 6 8
Abnormal heart rate recovery 1,572 (35%) 726 (37%) 314 (42%)
*By ECG.
ACE 5 angiotensin-converting enzyme; BP 5 blood pressure; ECG 5 electrocardiogram; METS 5 metabolic equivalents.
Figure 1. Seven-year mortality according to exercise test findings and
composite prognostic nuclear score among patients without a history of
prior revascularization. On the horizontal axis, “None” refers to patients
with at least average physical fitness and normal heart rate recovery; “One”
refers to patients with impaired physical fitness or abnormal heart rate
recovery, but not both; and “Two” refers to patients with both impaired
physical fitness and an abnormal heart rate recovery. The numbers
underneath each of the bars refers to the number of deaths (numerator) and
the total number of patients (denominator) in each subgroup.
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death, as was a severe-risk score (Table 3). Other indepen-
dent predictors of death included fair or poor physical
fitness and an abnormal heart rate recovery. Covariate-
adjusted survival functions according to nuclear scan results
are shown in Figure 4.
To validate these results, a series of bootstrap resamplings
with repetitive Cox proportional hazards modeling were
performed. First, 100 resamplings for variable selection
found that variables that entered models at least 90% of the
time included high-risk nuclear score (100%), age (100%),
abnormal heart rate recovery (100%), smoking (100%), use
of digoxin (99%), intermediate nuclear score (99%) and
diabetes (94%). A second set of 500 bootstrap resamplings
that adjusted for these variables along with others that
entered at least 50% of models demonstrated virtually
identical adjusted hazard ratios (for intermediate-risk score
adjusted hazard ratio: 1.50, 95% CI: 1.25 to 1.78; for
high-risk score adjusted hazard ratio: 2.91, 95% CI: 2.24 to
3.72).
DISCUSSION
Main findings. In this large cohort of patients referred for
symptom-limited exercise treadmill thallium201 SPECT
testing, myocardial perfusion defects were independently
predictive of long-term all-cause mortality, even after ac-
counting for clinical differences, exercise capacity and heart
rate recovery. Using information theory methods (25), we
identified a composite model that incorporated both evi-
dence of scar and ischemia as being best for prediction of
death.
Because of the long period of follow-up (mean of 6.7
years with a minimum of 4.5 years for survivors) and the
large number of outcome events (855 deaths), it was
possible to carefully assess the relative associations of nuclear
abnormalities and exercise test findings as risk predictors.
Among patients who had not undergone prior revascular-
ization (Fig. 1), exercise test findings could identify low-risk
(,1% per year) and high-risk (.3% per year) groups with
little additional prognostic information provided by nuclear
findings. Those patients who had either impaired functional
Table 3. Nuclear and Exercise Predictors of Risk of Death After











1.50 1.28 to 1.76 , 0.0001
High-risk
nuclear scan
2.76 2.13 to 2.56 , 0.0001
Poor or fair
fitness
2.34 2.00 to 2.76 , 0.0001
Abnormal heart
rate recovery
1.60 1.37 to 1.87 , 0.0001
*Covariates are listed in text.
Figure 3. Seven-year mortality according to exercise testing findings and
composite prognostic nuclear score among patients with a history of prior
percutaneous coronary interventions, but no history of prior coronary
bypass grafting. Horizontal axis labeling is the same as in Figure 1.
Figure 4. Survival according to thallium201 single photon emission com-
puted tomography findings after adjustments for covariates. Patients were
classified as having normal scans or scans with intermediate- or high-risk
findings based on the composite prognostic nuclear score discussed in detail
in the text. Dotted lines indicate 95% confidence limits.
Figure 2. Seven-year mortality according to exercise test findings and
composite prognostic nuclear score among patients with a history of prior
coronary artery bypass grafting. Horizontal axis labeling is the same as in
Figure 1.
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capacity or an abnormal heart rate recovery, but not both,
represented an intermediate-risk group for whom the nu-
clear test was particularly useful in stratifying risk, consistent
with the Bayesian theory (31).
Previous reports. A number of groups have demonstrated
prognostic associations between nuclear perfusion abnor-
malities and cardiac events (1,4). This study expounds upon
these in several respects. First, we found that nuclear
findings predict all-cause death. As has been discussed
elsewhere (10,11), the end point of “cardiac death” is
inherently suspect due to poor quality, biased recording of
death certificates and complexities of human disease (32).
All-cause death is a relevant end point in a cardiac popula-
tion, as shown in clinical trials in which an intervention
designed to treat cardiac disease resulted in reductions in
all-cause mortality (33).
Second, instead of comparing the nuclear scan with the
exercise electrocardiogram or the Duke treadmill score
(16,17), we compared it against functional capacity and
heart rate recovery; exercise findings are among the stron-
gest predictors of risk and are available in nearly all patients,
regardless of medication use or baseline electrocardiographic
abnormalities. Third, because of the large size of the cohort
and number of events, we could do robust subgroup analyses
of the prognostic usefulness of nuclear imaging among
patients with and without exercise test abnormalities.
Study limitations. The scintigraphic methods used in our
laboratory in the early 1990s (18,19) are not representative
of the most modern techniques available. Newer isotopes,
better acquisition protocols (34), gated SPECT imaging
(35) and attenuation correction (36) may mean that nuclear
images obtained now may have better prognostic value. By
studying patients who were imaged in the early 1990s,
however, we were able to analyze the impact of nuclear
findings on long-term outcome.
Defect severity for each segment was not examined in the
analysis. Whether defect severity might have had an impact
on our study is uncertain. It is possible that measures of
defect extent and severity might have both contributed to
the prognostic value of imaging. There are certain inherent
limitations with SPECT imaging techniques that funda-
mentally limit the ability to ascertain actual perfusion defect
severity (37).
Segments thought to represent attenuation were consid-
ered normal. This was the most conservative approach as
the appearance of artifacts may be surrogates for comorbid
conditions and elevate event rates in patients classified as
normal. Body mass index was not available. Exactly how
consideration of attenuation might have affected the prog-
nostic model is not entirely clear, as attenuation defects may
also be associated with leanness, which may itself be
associated with reduced mortality (38).
Other limitations are that our study was performed at a
single tertiary care center, leading to possible biases of
patient selection. We used bootstrapping to provide rela-
tively unbiased low-variance estimates of prediction without
having to sacrifice data for model development (28). None-
theless, confirmation of our results on entirely independent
external datasets is essential. We were unable to perform
detailed analyses of left ventricular dilation and increased
lung uptake of thallium. Formal measures of left ventricular
function were not available. We did exclude patients with
known heart failure or left ventricular systolic dysfunction,
though, and we accounted for use of digoxin and diuretics in
our multivariable analyses.
Conclusions. Despite these limitations, we found that
myocardial perfusion abnormalities as assessed by thalli-
um201 SPECT imaging are powerful and independent
predictors of long-term all-cause mortality. The value of
exercise nuclear imaging for risk stratification is particularly
enhanced when exercise capacity and heart rate recovery are
also considered.
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